NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - Get Free Report)'s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$4.77 and traded as high as C$5.05. NorthWest Health Prop Real Est Inv Trust shares last traded at C$5.03, with a volume of 457,784 shares trading hands.
Analyst Upgrades and Downgrades
Separately, National Bankshares lifted their target price on NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 and gave the stock an "outperform" rating in a report on Tuesday, March 11th.
View Our Latest Research Report on NWH.UN
NorthWest Health Prop Real Est Inv Trust Trading Down 0.8%
The company's 50 day moving average price is C$4.83 and its two-hundred day moving average price is C$4.77. The firm has a market cap of C$1.23 billion, a PE ratio of -3.14, a P/E/G ratio of 0.74 and a beta of 1.05. The company has a quick ratio of 0.06, a current ratio of 0.25 and a debt-to-equity ratio of 129.42.
About NorthWest Health Prop Real Est Inv Trust
(
Get Free Report)
NorthWest Healthcare Properties Real Estate Investment Trust TSX: NWH.UN (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.
Read More
Before you consider NorthWest Health Prop Real Est Inv Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NorthWest Health Prop Real Est Inv Trust wasn't on the list.
While NorthWest Health Prop Real Est Inv Trust currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
